Home

Pharmacology

Bipolar, Schizophrenia

Read time: 2 min

Congress highlights

The Double Burden of Diabetes and Severe Mental Illness

Although antipsychotics are the mainstay of treatment in severe mental illness (SMI), their use is...

Read time: 5 min

Satellite symposium

Targeting trace amine-associated receptors (TAARs) to treat schizophrenia

In this symposium titled ‘Novel TAARgets for stabilizing neural circuits in schizophrenia...

Alzheimer's Disease

Read time: 2 min

Congress highlights

Preventive and new therapeutic strategies

Current progress in preventive and new therapeutic strategies for Alzheimer’s disease were...

Read time: 3 min

Satellite symposium

Key considerations for women living with schizophrenia

In this symposium presented at the 35th ECNP Congress in Vienna, Austria (15th−18th Oct),...

Parkinson's Disease

Read time: 2 min

Congress highlights

Exercise and dopaminergic therapy for early Parkinson’s disease

What type of exercise should patients diagnosed with early Parkinson’s disease do to improve...

Depression, Schizophrenia

Read time: 4 min

Strategies for precision prescribing in psychiatry

In a symposium at CINP 2022 entitled ‘Strategies for Precision Prescribing in Psychiatry,...

Read time: 3 min

Congress highlights

Schizophrenia and the NMDA receptor – past, present and future

Professor Joseph Coyle (Harvard Medical School, USA) presented his work spanning 50 years on the...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country